Amyris/ US03236M2008 /
2023-08-18 10:00:00 PM | Chg. - | Volume | Bid1:59:04 AM | Ask1:58:37 AM | High | Low |
---|---|---|---|---|---|---|
0.0500USD | - | 46.75 mill. Turnover: 2.38 mill. |
0.0511Bid Size: 16,600 | 0.0530Ask Size: 12,000 | 0.0643 | 0.0500 |
GlobeNewswire
03-13
Liberation Labs Taps Biotech Biomanufacturing Veteran Rhys Dale to Assist with Development & Operati...
GlobeNewswire
2023-09-07
Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc...
GlobeNewswire
2022-02-03
Ingredion Incorporated Reports 2021 Results; Expects 7% to 9% Operating Income Growth for 2022
GlobeNewswire
2021-11-02
Ingredion Incorporated Reports Third Quarter 2021 Results and Raises Full Year Adjusted Earnings Exp...
GlobeNewswire
2021-05-03
Amyris and Ingredion Partner to Manufacture and Market Sugar Reduction and Fermentation-Based Food I...
GlobeNewswire
2019-09-12
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - A...
GlobeNewswire
2019-09-05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - ...
GlobeNewswire
2019-08-26
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - ...
GlobeNewswire
2019-08-21
Global Renewable Energy Market Analysis & Forecast, 2019-2023 with Profiles on Key Players Alstom Po...
GlobeNewswire
2019-06-28
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Inogen, Health Insurance In...
GlobeNewswire
2019-06-25
Renewable Chemicals: Global Market Forecast to 2024 with Profiles on 109 Industry Players
GlobeNewswire
2019-06-03
AMRS & CRCM - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Deadline